COVID-19 Coronavirus Antigen Microarray

SARS-CoV-2 is a betacoronavirus that is the cause of the COVID-19 global pandemic that began in 2019. SARS-CoV-2 infection of humans typically stimulates a strong humoral immunity response, leading to the production of both neutralizing and binding antibodies.

GeneCopoeia provides COVID-19-related antigen microarrays for two purposes: 1) Association of autoimmunity against cytokines with SARS-CoV-2 infection (Coronavirus Associated Autoimunity microarray, catalog # PA012); and 2) Detection of antibodies against SARS-CoV-2 (including variants of concern) and other pathogens (SARS-CoV-2 Coronavirus Variant Proteins microarray, catalog # PA013).

In addition to these predesigned arrays, arrays containing customized sets of proteins are available, as well as array profiling services and data analysis.

GeneCopoeia’s OmicsArray™ SARS-CoV-2 Coronavirus Antigen Microarrays are part of the GeneCopoeia OmicsArray™ Antigen Microarray family.

  • Multiplexing capable.  OmicsArray™ antigen microarrays can assay up to 120 antigens at a time, compared with 1 protein at a time for ELISA.
  • High throughput.  Each slide can process up to 15 samples in parallel.
  • High sensitivity.  Each array can detect as little as 1 pg/ml of antibody, which is 100-fold more sensitive than ELISA.
  • Small sample volume.  As little as 1 ul of serum is needed for detection.
  • Fast.  From sample-to-data in as little as 2 weeks.
Predesigned arrays Premade antigen microarrays GeneCopoeia’s OmicsArray™ COVID-19 Coronavirus Antigen Microarrays are premade protein microarrays. Please refer to the table below for more information.
Catalog number Number of Antigens Description
PA012 120 Human Coronavirus-associated Autoimmunity (CAA)
PA013 58 NEW! SARS-CoV-2 coronavirus variant proteins

User Manual

Custom protein microarrays are also available. To inquire about a custom protein microarray, please contact inquiry@genecopoeia.